What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
Takeshi Kimura mostly deals with Internal medicine, Surgery, Cardiology, Percutaneous coronary intervention and Stent.
His study ties his expertise on Endocrinology together with the subject of Internal medicine.
His Surgery study integrates concerns from other disciplines, such as Coronary artery disease and Radiology, Angioplasty.
His Angioplasty research is multidisciplinary, incorporating perspectives in Coronary arteries and Balloon.
Takeshi Kimura combines subjects such as Clopidogrel, Randomized controlled trial and Conventional PCI with his study of Percutaneous coronary intervention.
His Stent research includes elements of Odds ratio, Drug, Everolimus and Revascularization.
His most cited work include:
- Restenosis After Successful Percutaneous Transluminal Coronary Angioplasty: Serial Angiographic Follow-Up of 229 Patients (815 citations)
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis (759 citations)
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. (653 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Cardiology, Surgery, Percutaneous coronary intervention and Myocardial infarction are his primary areas of study.
In the field of Internal medicine, his study on Heart failure, Conventional PCI, Coronary artery disease and Hazard ratio overlaps with subjects such as In patient.
His Cardiology research includes themes of Stroke and Incidence.
Within one scientific family, Takeshi Kimura focuses on topics pertaining to Angioplasty under Surgery, and may sometimes address concerns connected to Balloon.
The study incorporates disciplines such as Clopidogrel, Acute coronary syndrome, Revascularization and Cohort in addition to Percutaneous coronary intervention.
His studies deal with areas such as Thrombosis and Everolimus as well as Stent.
He most often published in these fields:
- Internal medicine (57.84%)
- Cardiology (47.51%)
- Surgery (20.29%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (57.84%)
- Cardiology (47.51%)
- Percutaneous coronary intervention (19.38%)
In recent papers he was focusing on the following fields of study:
Takeshi Kimura spends much of his time researching Internal medicine, Cardiology, Percutaneous coronary intervention, Heart failure and Myocardial infarction.
Takeshi Kimura connects Internal medicine with In patient in his research.
His research integrates issues of Stroke and Clinical endpoint in his study of Cardiology.
His Percutaneous coronary intervention research is multidisciplinary, relying on both Stent, Clopidogrel, Conventional PCI and Dabigatran.
His Heart failure research incorporates themes from Lower risk and Stenosis, Aortic valve replacement.
His Stenosis study combines topics in areas such as Asymptomatic and Surgery.
Between 2018 and 2021, his most popular works were:
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial (230 citations)
- Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk (189 citations)
- JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ― (103 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Gene
His primary areas of study are Internal medicine, Cardiology, Percutaneous coronary intervention, In patient and Heart failure.
His Myocardial infarction, Hazard ratio, Incidence, Atrial fibrillation and Randomized controlled trial study are his primary interests in Internal medicine.
His Myocardial infarction research focuses on subjects like Coronary artery disease, which are linked to Emergency medicine.
His Cardiology research is multidisciplinary, incorporating elements of Percutaneous and Adverse effect.
The various areas that Takeshi Kimura examines in his Percutaneous coronary intervention study include Stent, Coronary stent, Clinical trial and Conventional PCI.
His Stent study deals with the bigger picture of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
